Apogee Therapeutics, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
APGE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
221 Crescent St., Building 17, Suite 102 B, Waltham, Massachusetts

Insiders trading volume in the past year

Apogee Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director $80.1 M Jun 5, 2024
Nimish Shah Director $65.2 M Jun 5, 2024
Michael Henderson Chief Executive Officer, Director $54.9 M -$559 K -1.01% Jul 5, 2024
Carl Dambkowski Chief Medical Officer $11.2 M -$225 K -1.96% Jul 3, 2024
Jane Henderson Chief Financial Officer $7.71 M Dec 18, 2023
William Jones Director $1.3 M Jun 5, 2024
Jennifer Fox Director $1.3 M Jun 5, 2024
Mark C. McKenna Director Jun 5, 2024
Lisa Bollinger Director Jun 5, 2024
Andrew Gottesdiener Director Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Apogee Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership